APA (7th ed.) Citation

F, S., C, T., L, C., E, G., G, G., L, S., . . . F, B. (2024). Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents. British journal of haematology, 205(5), 1873. https://doi.org/10.1111/bjh.19658

Chicago Style (17th ed.) Citation

F, Spriano, et al. "Targeting CD25+ Lymphoma Cells with the Antibody-drug Conjugate Camidanlumab Tesirine as a Single Agent or in Combination with Targeted Agents." British Journal of Haematology 205, no. 5 (2024): 1873. https://doi.org/10.1111/bjh.19658.

MLA (9th ed.) Citation

F, Spriano, et al. "Targeting CD25+ Lymphoma Cells with the Antibody-drug Conjugate Camidanlumab Tesirine as a Single Agent or in Combination with Targeted Agents." British Journal of Haematology, vol. 205, no. 5, 2024, p. 1873, https://doi.org/10.1111/bjh.19658.